Genomics remains the largest platform, while single-cell multiomics and metabolomics are set for fastest growth as pharma and biotech R&D spending accelerates worldwide.Austin, Sept. 26, 2025 (GLOBE ...
Discover why Micron Technology (MU) is a strong buy in 2025, driven by AI, data center demand, boosted margins, and record ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback